Versant Capital Management, Inc Becton Dickinson & CO Transaction History

Versant Capital Management, Inc

$431 Million
Q3 2024

A detailed history of Versant Capital Management, Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Versant Capital Management, Inc holds 135 shares of BDX stock, worth $30,638. This represents 0.01% of its overall portfolio holdings.

Number of Shares

135

Previous 69 95.65%

Holding current value

$30,638

Previous $16,000 100.0%

% of portfolio

0.01%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$221.47 - $242.41 $14,617 - $15,999	66 Added 95.65%	135 $32,000
Q2 2024 Jul 05, 2024	SELL	$225.07 - $246.17 $6,076 - $6,646	-27 Reduced 28.13%	69 $16,000
Q1 2024 Apr 03, 2024	SELL	$233.45 - $247.73 $67,933 - $72,089	-291 Reduced 75.19%	96 $23,000
Q4 2023 Jan 08, 2024	SELL	$232.24 - $267.23 $696 - $801	-3 Reduced 0.77%	387 $94,000
Q3 2023 Oct 11, 2023	BUY	$254.9 - $283.59 $254 - $283	1 Added 0.26%	390 $100,000
Q2 2023 Jul 10, 2023	BUY	$238.39 - $265.32 $1,191 - $1,326	5 Added 1.3%	389 $102,000
Q1 2023 Apr 10, 2023	BUY	$229.71 - $259.35 $65,007 - $73,396	283 Added 280.2%	384 $95,000
Q1 2022 Apr 29, 2022	SELL	$243.64 - $270.48 $730 - $811	-3 Reduced 2.88%	101 $27,000
Q4 2021 Jan 06, 2022	SELL	$230.08 - $250.94 $1,380 - $1,505	-6 Reduced 5.45%	104 $26,000
Q3 2021 Oct 29, 2021	SELL	$232.72 - $256.47 $930 - $1,025	-4 Reduced 3.51%	110 $27,000
Q4 2020 Feb 08, 2021	BUY	$221.92 - $245.94 $665 - $737	3 Added 2.7%	114 $28,000
Q2 2020 Jul 16, 2020	SELL	$219.9 - $263.41 $1,319 - $1,580	-6 Reduced 5.13%	111 $26,000
Q1 2020 Apr 17, 2020	SELL	$195.69 - $279.01 $2,739 - $3,906	-14 Reduced 10.69%	117 $26,000
Q4 2019 Jan 28, 2020	SELL	$236.45 - $266.82 $5,674 - $6,403	-24 Reduced 15.48%	131 $35,000
Q2 2019 Jul 16, 2019	SELL	$217.4 - $246.08 $8,478 - $9,597	-39 Reduced 20.1%	155 $39,000
Q1 2019 Apr 23, 2019	BUY	$206.05 - $248.17 $30,083 - $36,232	146 Added 304.17%	194 $48,000
Q1 2019 Apr 23, 2019	SELL	$206.05 - $248.17 $30,495 - $36,729	-148 Reduced 75.51%	48 $48,000
Q3 2018 Oct 15, 2018	SELL	$233.07 - $256.0 $1,398 - $1,536	-6 Reduced 2.97%	196 $51,000
Q2 2018 Jul 06, 2018	SELL	$208.1 - $233.85 $4,578 - $5,144	-22 Reduced 9.82%	202 $48,000
Q1 2018 Apr 19, 2018	SELL	$205.46 - $240.27 $200,323 - $234,263	-975 Reduced 81.32%	224 $48,000
Q4 2017 Apr 19, 2018	BUY	$189.0 - $222.64 $194,481 - $229,096	1,029 Added 605.29%	1,199 $256,000
Q3 2017 Apr 23, 2018	BUY	$186.89 - $198.9 $1,121 - $1,193	6 Added 3.66%	170 $33,000
Q4 2016 Apr 23, 2018	SELL	N/A	-17 Reduced 9.39%	164 $27,000
Q3 2016 Apr 23, 2018	SELL	N/A	-4 Reduced 2.16%	181 $32,000
Q2 2016 Apr 23, 2018	SELL	N/A	-1 Reduced 0.54%	185 $31,000
Q1 2016 Apr 23, 2018	SELL	N/A	-8 Reduced 4.12%	186 $28,000
Q4 2015 Apr 23, 2018	BUY	N/A	194	194 $29,000

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account

Versant Capital Management, Inc Becton Dickinson & CO Transaction History